We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current NTRA market cap is 10.63B. The company's latest EPS is USD -3.6006 and P/E is -24.22.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 210.64M | 217.25M | 241.76M | 261.4M | 268.31M |
| Operating Income | -119.05M | -141.77M | -138.3M | -112.43M | -110.98M |
| Net Income | -121.48M | -142.57M | -136.94M | -111.05M | -108.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 316.72M | 391.01M | 625.49M | 820.22M | 1.08B |
| Operating Income | -116.29M | -216.28M | -468.17M | -541.04M | -446.25M |
| Net Income | -124.83M | -229.74M | -471.72M | -547.8M | -434.8M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.01B | 1.39B | 1.32B | 1.25B | 1.45B |
| Total Liabilities | 647.49M | 688.73M | 668.31M | 651.75M | 661.86M |
| Total Equity | 361.62M | 705.74M | 650.57M | 596.15M | 784.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 582.66M | 932.15M | 1.24B | 1.39B | 1.44B |
| Total Liabilities | 303.95M | 445.92M | 583.18M | 688.73M | 676.37M |
| Total Equity | 278.71M | 486.24M | 653.3M | 705.74M | 765.33M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -350.37M | -431.5M | -80.89M | -159.28M | -188.83M |
| Investing | 308.42M | 330.34M | 15.65M | 62.68M | 143.83M |
| Financing | 14.47M | 482.64M | 2.3M | 11.61M | 247.62M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -63.44M | -182.51M | -335.24M | -431.5M | -246.96M |
| Investing | -266.35M | -331.46M | -205.19M | 330.34M | 168.5M |
| Financing | 340.77M | 500.85M | 576.19M | 482.64M | 254.46M |
| Market Cap | 10.63B |
| Price to Earnings Ratio | -24.22 |
| Price to Sales Ratio | 9.73 |
| Price to Cash Ratio | 16.4 |
| Price to Book Ratio | 13.76 |
| Dividend Yield | - |
| Shares Outstanding | 120.76M |
| Average Volume (1 week) | 1.06M |
| Average Volume (1 Month) | 1.19M |
| 52 Week Change | 71.34% |
| 52 Week High | 98.82 |
| 52 Week Low | 36.90 |
| Spread (Intraday) | 2.7 (3.06%) |
| Company Name | Natera Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.natera.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
